(Q36961600)

17 August 2017

1 reference

title

The origin and application of experimental autoimmune encephalomyelitis (English)

1 reference

experimental autoimmune encephalomyelitis

17 August 2017

0 references

author name string

Alan G Baxter

series ordinal

1

1 reference

17 August 2017

1 November 2007

1 reference

Nature Reviews Immunology

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

904-912

1 reference

17 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nri2190

17 August 2017

0 references

cites work

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

1 reference

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

31 March 2020

1 reference

The Neuro-Paralytic Accidents of Anti-Rabies Treatment

31 March 2020

1 reference

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

31 March 2020

1 reference

ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS

31 March 2020

1 reference

THE ANTIBODY RESPONSE OF RABBITS TO INJECTIONS OF EMULSIONS AND EXTRACTS OF HOMOLOGOUS BRAIN.

31 March 2020

1 reference

THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS.

31 March 2020

1 reference

ALLERGIC ENCEPHALOMYELITIS IN MONKEYS IN RESPONSE TO INJECTION OF NORMAL MONKEY NERVOUS TISSUE.

31 March 2020

1 reference

The pathology of acute disseminated encephalomyelitis produced experimentally in the rhesus monkey and its resemblance to human demyelinating disease

31 March 2020

1 reference

Disseminated encephalomyelitis experimentally produced by the use of homologous antigen

31 March 2020

1 reference

Experimental disseminated encephalomyelitis in white mice

31 March 2020

1 reference

Encephalomyelitis in the rat following intracutaneous injection of central nervous system tissue with adjuvant

31 March 2020

1 reference

Acute disseminated encephalomyelitis following immunization with homologous brain extracts; studies on the role of a circulating antibody in the production of the condition in dogs

31 March 2020

1 reference

Experimental "allergic" encephalitis: attempts to produce the disease in sheep and goats

31 March 2020

1 reference

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

31 March 2020

1 reference

Effect of homologous spinal cord in Freund's adjuvant on cockerel comb, testicular and body growth

31 March 2020

1 reference

The morbid anatomy of the demyelinative disease

31 March 2020

1 reference

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

31 March 2020

1 reference

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

31 March 2020

1 reference

Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone

31 March 2020

1 reference

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

31 March 2020

1 reference

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

31 March 2020

1 reference

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

31 March 2020

1 reference

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

31 March 2020

1 reference

A study of the chemical nature of components of bovine white matter effective in producing allergic encephalomyelitis in the rabbit

31 March 2020

1 reference

Production of experimental encephalomyelitis with calcium acetate compound extracted from brain tissue

31 March 2020

1 reference

The encephalomyelitic activity of myelin isolated by ultracentrifugation

31 March 2020

1 reference

THE ISOLATION FROM BOVINE SPINAL CORD OF A HOMOGENEOUS PROTEIN WITH ENCEPHALITOGENIC ACTIVITY

31 March 2020

1 reference

Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins

31 March 2020

1 reference

T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis

31 March 2020

1 reference

Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis

31 March 2020

1 reference

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

31 March 2020

1 reference

Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized

31 March 2020

1 reference

The V-region disease hypothesis: evidence from autoimmune encephalomyelitis

31 March 2020

1 reference

Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein

31 March 2020

1 reference

Murine T-cell receptor mutants with deletions of beta-chain variable region genes

31 March 2020

1 reference

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

31 March 2020

1 reference

Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins

31 March 2020

1 reference

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

31 March 2020

1 reference

NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients

31 March 2020

1 reference

Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes

31 March 2020

1 reference

Antigen-specific therapies for the treatment of multiple sclerosis: a clinical trial update

31 March 2020

1 reference

A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis

31 March 2020

1 reference

31 March 2020

1 reference

A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis

31 March 2020

1 reference

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

31 March 2020

1 reference

Therapeutic vaccines in autoimmunity

31 March 2020

1 reference

Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation

31 March 2020

1 reference

PANEL DISCUSSION ON SPECIES VARIABILITY AND MULTIPLE ANTIGENS IN EAE: SUMMARY STATEMENT

31 March 2020

1 reference

The coming of age for antigen-specific therapy of multiple sclerosis

31 March 2020

1 reference

MBP-PLP fusion protein-induced EAE in C57BL/6 mice

31 March 2020

1 reference

Nerve inflammation halts trial for Alzheimer's drug.

31 March 2020

1 reference

Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide

31 March 2020

1 reference

Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination

31 March 2020

1 reference

PROPAGATION OF RABIES VIRUS IN TISSUE CULTURE.

31 March 2020

1 reference

Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes

31 March 2020

1 reference

On lawnmowers and lay-down misères.

31 March 2020

1 reference

Experimental Allergic Encephalomyelitis: Synthesis of Disease-Inducing Site of the Basic Protein

31 March 2020

1 reference

Biological Activity and Synthesis of an Encephalitogenic Determinant

31 March 2020

1 reference

The major site of guinea-pig myelin basic protein encephalitogenic in Lewis rats

31 March 2020

1 reference

Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein

31 March 2020

1 reference

Amino acid sequence of the encephalitogenic basic protein from human myelin

31 March 2020

1 reference

Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity

31 March 2020

1 reference

Relationship of homologous brain proteolipid to allergic encephalomyelitis in guinea pigs.

31 March 2020

1 reference

Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice.

31 March 2020

1 reference

Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat

31 March 2020

1 reference

Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.

31 March 2020

1 reference

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.

31 March 2020

1 reference

The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS).

31 March 2020

1 reference

T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.

31 March 2020

1 reference

Rapid Production of Acute Disseminated Encephalomyelitis in Rhesus Monkeys by Injection of Brain Tissue With Adjuvants.

31 March 2020

1 reference

Transfer of allergic encephalomyelitis in rats by means of lymph node cells

31 March 2020

1 reference

The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type

31 March 2020

1 reference

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

31 March 2020

1 reference

Synergism in the pathogenesis of EAE induced by an MBP-specific T-cell line and monoclonal antibodies to galactocerebroside or a myelin oligodendroglial glycoprotein

31 March 2020

1 reference

Role of CD8+ T cells in murine experimental allergic encephalomyelitis

31 March 2020

1 reference

Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice

31 March 2020

1 reference

In healthy primates, circulating autoreactive T cells mediate autoimmune disease

31 March 2020

1 reference

Mice lacking αβ+ T cells are resistant to the induction of experimental autoimmune encephalomyelitis

31 March 2020

1 reference

Attenuation of experimental autoimmune demyelination in complement-deficient mice

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI2190

1 reference

PubMed ID

17917672

Dimensions Publication ID

17 August 2017

0 references

1 reference

PubMed ID

17917672